DiaMedica Therapeutics Inc. , a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that the Company's management will attend ...
Foundation is pleased to announce receipt of a $7 million grant from the John C. Martin Foundation to sustain and expand the Polaris Observatory until the end of 2030. The Polaris Observatory serves ...
This collaboration strengthens the commitment of both companies to advance clinical research, leveraging Novotech’s expertise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback